Skip to content

Study for effect of Liangge Powder in the treatment of Acute gastrointestinal disorders with sepsis

Study for effect of Liangge Powder in the treatment of Acute gastrointestinal disorders with sepsis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087202
Enrollment
Unknown
Registered
2024-07-22
Start date
2023-02-06
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute gastrointestinal disorder with sepsis

Interventions

Experimental group :Liangge Powder Decoction
Control group:Blank control

Sponsors

Shuguang Hospital affiliated to Shanghai University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Patients who meet the diagnostic criteria of Western medicine for acute gastrointestinal disorders of sepsis; 2) AGI level I-III; 3) People between the ages of 18 and 85, regardless of gender; 4) Gastrointestinal safety, no enteral nutrition (EN) contraindications; 5) Patients and/or immediate family members understand and agree to this study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1) in the terminal stage of various diseases; 2) The primary disease is gastrointestinal disease, such as peptic ulcer, atrophic gastritis, and gastrointestinal resection, gastrointestinal or abdominal surgery recovery; 3) patients with malignant tumors; 4) Mental illness; 5) Pregnant and lactating women; 6) Patients with severe allergy to Chinese medicine; 7) Patients with antibiotic application that has a greater impact on gastrointestinal tract were excluded.

Design outcomes

Primary

MeasureTime frame
Acute gastrointestinal injury grading;

Secondary

MeasureTime frame
28-day survival rate;Acute Physiology and Chronic Health Evaluation;Classification of bowel sounds;Gastric residual volume;Sequential organ failure score;D-lactic acid;Diamine oxidase;Endotoxin;

Countries

China

Contacts

Public ContactYue Jin

Shuguang Hospital affiliated to Shanghai University of TCM

jinyue5125@163.com+86 131 2226 4896

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026